Premium
The controversy around technical standards for similar biotherapeutics: barriers to access and competition? †
Author(s) -
González Claudia Patricia Vaca,
Muñoz Carolina Gómez
Publication year - 2020
Publication title -
pharmacoepidemiology and drug safety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.023
H-Index - 96
eISSN - 1099-1557
pISSN - 1053-8569
DOI - 10.1002/pds.5100
Subject(s) - medicine , competition (biology) , ecology , biology
Correspondence Claudia Patricia Vaca González. Pharmacist. Pharmacoepidemiologist. Professor at the National University of Colombia. Director of the National University's Think Tank “Medicines, Information and Power”. Former Senior Advisor to the Minister of Health of Colombia. Member of WHO Advisory Committee on Safety of Medicinal Products. Email: cpvacag@unal.edu.co Carolina Gómez Muñoz. Lawyer. LLM UC Berkeley. Member of National University's Think Tank “Medicines, Information and Power”. Former Director of Medicines and Health Technologies, Ministry of Health of Colombia. Email: cagomezmu@unal.edu.co